Copy to clipboard 
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics signed a partnership with Highridge Medical whereby Highridge’s surgeon customers will gain access to SMAIO’s full spinal realignment planning capabilities and the ability to combine SMAIO’s technology with their existing implant systems in a modular and open configuration.
This agreement marks the launch of SMAIO’s open platform KEOPS-4ME, aimed at providing surgeons across the U.S. with its personalized and data-driven approach to complex spine surgery, including data analysis, 3D surgery planning, KEOPS balance Analyzer 3D, and use of the patient-specific K-Rods.
This collaboration will provide SMAIO with access to Highridge’s U.S hospital network, facilitated implant registration and broader clinical adoption. With hospital registration processes and FDA 510(k) clearances underway, the partners expect to begin marketing their first joint solutions in early 2026.
Philippe Roussouly, Chairman and CEO of SMAIO, stated: “We are thrilled to announce this partnership, which represents another significant milestone in our U.S. growth strategy and is the first major partnership in building our open platform KEOPS-4ME to scale SMAIO technology distribution across the US market. It confirms the relevance of our approach based on combining implants with software and data analysis for the benefit of spinal surgery. Working with Highridge Medical gives us immediate access to a highly qualified commercial network, already active in top-tier hospitals. It is a powerful accelerator for the adoption of our technology in this key market.”
“As we continue to develop and expand our complex spine portfolio, we are very excited about this partnership with SMAIO,” said Rebecca Whitney, CEO of Highridge Medical. “The addition of a 3-D pre-operative planning solution with proprietary algorithms that enable the design of patient-specific spinal rods will be a great benefit to our surgeon customers and the patients they serve.”
Source: SMAIO
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics signed a partnership with Highridge Medical whereby Highridge’s surgeon customers will gain access to SMAIO’s full spinal realignment planning capabilities and the ability to combine SMAIO’s technology with their existing implant systems in a modular and open configuration.
This...
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics signed a partnership with Highridge Medical whereby Highridge’s surgeon customers will gain access to SMAIO’s full spinal realignment planning capabilities and the ability to combine SMAIO’s technology with their existing implant systems in a modular and open configuration.
This agreement marks the launch of SMAIO’s open platform KEOPS-4ME, aimed at providing surgeons across the U.S. with its personalized and data-driven approach to complex spine surgery, including data analysis, 3D surgery planning, KEOPS balance Analyzer 3D, and use of the patient-specific K-Rods.
This collaboration will provide SMAIO with access to Highridge’s U.S hospital network, facilitated implant registration and broader clinical adoption. With hospital registration processes and FDA 510(k) clearances underway, the partners expect to begin marketing their first joint solutions in early 2026.
Philippe Roussouly, Chairman and CEO of SMAIO, stated: “We are thrilled to announce this partnership, which represents another significant milestone in our U.S. growth strategy and is the first major partnership in building our open platform KEOPS-4ME to scale SMAIO technology distribution across the US market. It confirms the relevance of our approach based on combining implants with software and data analysis for the benefit of spinal surgery. Working with Highridge Medical gives us immediate access to a highly qualified commercial network, already active in top-tier hospitals. It is a powerful accelerator for the adoption of our technology in this key market.”
“As we continue to develop and expand our complex spine portfolio, we are very excited about this partnership with SMAIO,” said Rebecca Whitney, CEO of Highridge Medical. “The addition of a 3-D pre-operative planning solution with proprietary algorithms that enable the design of patient-specific spinal rods will be a great benefit to our surgeon customers and the patients they serve.”
Source: SMAIO
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
